Current Issue
Volume: 38
Number: 2
Index: June 2010
Clinical Focus: Orthopedics and Ligament Injuries
Editorial Calendar
October 2010
Clinical Focus: Neurology, Stroke, Rehabilitation Medicine/ Emergency Medicine, Cardiometabolic Health
  • Neurology and Stroke
    • Postconcussive outcomes in athletes
    • Peroneal nerve injuries/palsy
    • Exercise and Parkinson's disease
    • Boxing-related neurological injuries
    • Reduction in incident stroke risk with physical activity
  • Rehabilitation Medicine/Emergency Medicine
    • Sport and recreation related injuries/fracture
    • Recognizing symptoms of concussion/trauma during sports event
    • Sports dentistry
  • Cardiometabolic Health
    • Obesity and diabetes in sports medicine
    • Athletes and vitamin D
    • Omega-3 fatty acids (over the counters vs subscriptions)
    • IBS and nutrition
    • Bone health in patients with gastrointestinal disorders
    • Malabsorption and nutrition intake/electrolytes/fluids
    • Malabsorption and high fructose intake
  • Using erythropoietin to increase performance
  • Adherence after gastric bypass surgery and exercise
  • Exercises to help manage neck pain
  • Myotonia congenita
  • Spinal disc herniation
  • Steroid-induced osteoporosis in men
  • On-the-field injury treatment
  • Return-to-play strategies
  • Water sports injuries
  • Post-transplant patients and exercise
View More
Submission deadline: September 05
Fast-Track deadline: September 15
Fast-Track
About
Fast-Track peer review is available for those papers requiring immediate review (for an additional fee). Complete peer review is finalized in 1-2 weeks and comments are provided to the author within 72 hours of their receipt by the editorial office. Authors are asked to submit a revised manuscript within 10-12 days. Accepted manuscripts are processed within 2-3 weeks, published online within 3 business days of final author approval, and in print in the next available issue.
Submissions
Submit your FAST-TRACK manuscript online today. It's fast, it's easy! Just follow the detailed instructions, fill in all the required fields, and upload your manuscript.
Get started NOW!
Contacts
Libraries:
sitelicenses@physsportsmed.com

Reprints:
reprints@physsportsmed.com

Subscriptions:
subscriptions@physsportsmed.com

Supplements:
supplements@physsportsmed.com

Document Delivery Services
1986-2010:

documentdelivery@physsportsmed.com

Editorial:
editor-in-chief@physsportsmed.com editorial@physsportsmed.com

Website:
support@physsportsmed.com

Managing Director:
John Elduff
Phone: 610-889-3732
Fax: 1-866-297-3168
j.elduff@physsportsmed.com

General Information
Phone: 610-889-3730
Fax: 1-866-297-3168
1235 Westlakes Drive
Suite 320
Berwyn, PA 19312
doi: 10.3810/psm.2008.12.7
The Physician and Sportsmedicine: Volume 36: No.1
Effect of Fish Oil-Derived Omega-3 Polyunsaturated Fatty Acid Supplementation on Exercise-Induced Bronchoconstriction and Immune Function in Athletes
Timothy D. Mickleborough, PhD; Martin R. Lindley, PhD; And Gregory S. Montgomery, MD
Abstract: Exercise-induced bronchoconstriction (EIB) is a condition in which vigorous physical activity triggers acute airway obstruction in asthmatic and nonasthmatic individuals with hyperresponsive airways. Studies have shown that inflammatory mediators and contraction of airway smooth muscle are central components in the pathogenesis of EIB, and it has long been recognized that leukotrienes and prostaglandins play an important role in the EIB response. Clinical responses to current therapy, such as leukotriene modifiers and corticosteroids are heterogeneous, and even with optimal treatment there is a substantial burden of unaddressed disease. While daily medications such as leukotriene modifiers provide only modest protection against symptoms, prolonged use of several medications can result in reduced effectiveness or tachyphylaxis. Although the treatment of EIB almost exclusively involves pharmacotherapy, there is now convincing evidence that dietary modification has the potential to reduce the severity of this condition. Omega-3 polyunsaturated fatty acids, such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in fish oils, compete with arachidonic acid as substrates for the formation of proinflammatory mediators, such as leukotrienes, prostaglandins, and cytokines. Studies have shown that 3 weeks of fish oil supplementation, rich in EPA and DHA, reduces exercise-induced airway narrowing, airway inflammation, and bronchodilator use in elite athletes and asthmatic individuals with EIB. Based on the evidence to date, fish oil supplementation may represent a potentially beneficial treatment intervention for athletes and asthmatic individuals with EIB. From this, it follows that physicians should pay more attention to what their asthma/EIB patients eat, and incorporate dietary assessment and nutritional counseling in their everyday practice.

Keywords: omega-3; polyunsaturated fatty acid; fish oil; exercise-induced bronchoconstriction

(read)

Back to the table of contents for the December 2008 issue